Home/Pipeline/IMW‑002

IMW‑002

Acromegaly / Neuroendocrine Tumors

Phase 1Active

Key Facts

Indication
Acromegaly / Neuroendocrine Tumors
Phase
Phase 1
Status
Active
Company

About Immunwork

Taiwan biotech creating ultra‑long‑acting endocrine drugs and antibody‑based oncology candidates.

View full company profile

Therapeutic Areas